Treatment of Rapid Onset Obesity, Hypoventilation, Hypothalamic Dysfunction, and Autonomic Dysregulation (ROHHAD )
NCT02441491
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Inadequate accrual
Conditions
ROHHAD Syndrome
Interventions
DRUG:
Cyclophosphamide
Sponsor
Johns Hopkins University